首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1561041

微生物鑑定市場規模、佔有率、成長分析、按產品和服務、按方法、按技術、按地區 - 行業預測，2024-2031 年

Microbial Identification Market Size, Share, Growth Analysis, By Product & Service, By Method, By Technology, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球微生物鑑定市場規模為45億美元，從2023年的50.6億美元成長到2031年的128.9億美元，複合年成長率預計將成長12.40%。

由於感染疾病率的上升以及人們日益認知到微生物鑑定在疾病診斷和治療中的重要作用，全球微生物鑑定市場正在顯著成長。醫療保健、製藥、食品和飲料以及環境監測等各領域對快速、準確的識別方法的需求不斷增加。自動化系統、分子診斷和基因組學等技術創新大大增強了微生物鑑定過程，從而獲得更快、更準確的結果。此外，研究機構、生物技術和製藥公司擴大使用微生物鑑定正在推動市場發展。新感染疾病的出現以及對抗菌素抗藥性日益成長的擔憂凸顯了有效識別方法和增加該領域投資的必要性。此外，對個人化醫療的關注和對即時檢測的需求也有助於市場擴張。然而，先進識別技術的高成本以及熟練專業人員的缺乏給成長帶來了挑戰。儘管存在這些障礙，持續的研究和開發工作預計將推動全球微生物鑑定市場的發展，創造創新機會，並改善全球患者照護。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

bioMerieux SA（France）
Becton, Dickinson and Company（BD）（US）
Thermo Fisher Scientific Inc.（US）
Danaher Corporation（US）
Merck KGaA（Germany）
Bruker Corporation（US）
Shimadzu Corporation（Japan）
Qiagen NV（Netherlands）
Avantor, Inc.（US）
Accelerate Diagnostics, Inc.（US）
Biolog, Inc.（US）
Liofilchem Srl（Italy）
Trivitron Healthcare（India）
Gradian Diagnostics（US）
Alifax Srl（Italy）
HiMedia Laboratories（India）
i2a SA（France）
Zhuhai DL Biotech Co., Ltd.（China）
GeneFluidics, Inc.（US）
Creative Diagnostics（US）

簡介目錄

Product Code: SQMIG35J2067

Global Microbial Identification Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 5.06 billion in 2023 to USD 12.89 billion by 2031, growing at a CAGR of 12.40% during the forecast period (2024-2031).

The global microbial identification market is experiencing notable growth due to the rising incidence of infectious diseases and increasing awareness of the critical role microbial identification plays in disease diagnosis and treatment. The demand for rapid and accurate identification methods is growing across various sectors such as healthcare, pharmaceuticals, food and beverage, and environmental monitoring. Technological innovations, including automated systems, molecular diagnostics, and genomics, have significantly enhanced the microbial identification process, enabling faster and more precise results. The market is further driven by the increasing use of microbial identification in research institutions, biotechnology, and pharmaceutical companies. The emergence of new infectious diseases and the growing concern over antimicrobial resistance have underscored the need for effective identification methods, leading to increased investment in this field. Additionally, the focus on personalized medicine and the demand for point-of-care testing are contributing to the market's expansion. However, high costs associated with advanced identification technologies and a shortage of skilled professionals present challenges to growth. Despite these hurdles, ongoing research and development efforts are expected to drive the global microbial identification market forward, creating opportunities for innovation and enhancing patient care worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbial Identification market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbial Identification Market Segmental Analysis

Global Microbial Identification Market is segmented by Product & Service, Method, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into Instruments & Software, Consumables, and Services. Based on Method, the market is segmented into Phenotypic Methods, Proteomics-Based Methods, and Genotypic Methods. Based on Technology, the market is segmented into Mass Spectrometry-Based Microbial Identification Market, PCR Based Microbial Identification Market, Flow Cytometry Based Microbial Identification Market, Microscopy Based Microbial Identification Market, and Other Microbial Identification Technologies. Based on Application, the market is segmented into Diagnostic Applications Pharmaceutical Applications, Food Testing, Beverage Testing, Cosmetics and Personal Care Products Testing, Environmental Applications, and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Blood Banks, Pharmaceutical Companies & Contract Research Organizations, Food Manufacturing Companies, Beverage Manufacturing Companies, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Microbial Identification Market

A major factor driving the growth of the global microbial identification market is the rising prevalence of infectious diseases. The increasing number of infections worldwide has created a strong demand for precise and rapid microbial identification methods, essential for timely diagnosis and effective treatment. This growing need is further amplified by factors like population growth, globalization, and the emergence of new drug-resistant pathogens. These trends emphasize the critical role of reliable microbial identification in healthcare environments, as it aids in combating the spread of infections and ensuring appropriate medical interventions.

Restraints in the Global Microbial Identification Market

A significant restraint in the global microbial identification market is the high cost of advanced identification techniques. Although technological advancements have enhanced the precision and speed of microbial identification, these improvements often come with a hefty price. The expense of acquiring and maintaining advanced equipment, along with the costs of staff training and necessary consumables, can be a financial burden for many. This high cost presents particular challenges for smaller healthcare facilities and regions with limited resources, restricting their ability to adopt these advanced methods. As a result, the widespread implementation of cutting-edge microbial identification techniques is limited, which can slow down market growth to some extent.

Market Trends of the Global Microbial Identification Market

A notable trend in the microbial identification market is the growing adoption of automation and advanced technologies. Laboratories and healthcare facilities are increasingly utilizing automated systems, along with innovative tools such as molecular diagnostics, genomics, and artificial intelligence (AI), to improve the efficiency, precision, and speed of microbial identification. Automation helps streamline processes, minimizes human error, and supports high-throughput testing, resulting in faster and more accurate results. The integration of these advanced technologies provides researchers and clinicians with deeper insights, enabling them to make well-informed decisions and ultimately improve patient care. This trend is largely driven by the rising need for rapid, accurate identification methods, particularly in response to emerging infectious diseases, antimicrobial resistance, and the growing emphasis on personalized medicine.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Supply chain Analysis
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Microbial Identification Market by Product & Service

Market Overview
Instruments & Software
Consumables
- Panels/Id Cards & Media
- Kits
- Other Consumables
Services

Microbial Identification Market by Method

Market Overview
Phenotypic Methods
Proteomics-Based Methods
Genotypic Methods

Microbial Identification Market by Technology

Market Overview
Mass Spectrometry-Based Microbial Identification Market
Pcr Based Microbial Identification Market
Flow Cytometry Based Microbial Identification Market
Microscopy Based Microbial Identification Market
Other Microbial Identification Technologies

Microbial Identification Market by Application

Market Overview
Diagnostic Applications
- Human Disease Diagnosis
- Animal Disease Diagnosis
Pharmaceutical Applications
Food Testing
Beverage Testing
Cosmetics And Personal Care Products Testing
Environmental Applications
Other Applications

Microbial Identification Market, By End User

Hospitals, Diagnostic Laboratories, and Blood Banks
Pharmaceutical Companies & Contract Research Organizations
Food Manufacturing Companies
Beverage Manufacturing Companies
Other End Users

Microbial Identification Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolog, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Liofilchem S.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gradian Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alifax S.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
i2a SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhuhai DL Biotech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneFluidics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments